These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23038092)

  • 21. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of ventricular resynchronization reserve by radionuclide phase analysis in heart failure patients: a prospective long-term study.
    Dauphin R; Nonin E; Bontemps L; Vincent M; Pinel A; Bonijoly S; Barborier D; Ribier A; Fernandes CM; Bert-Marcaz P; Itti R; Chevalier P
    Circ Cardiovasc Imaging; 2011 Mar; 4(2):114-21. PubMed ID: 21239562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of change in serum bilirubin in predicting left ventricular reverse remodeling and outcomes in heart failure patients with cardiac resynchronization therapy.
    Hosoda J; Ishikawa T; Matsumoto K; Iguchi K; Matsushita H; Ogino Y; Taguchi Y; Sugano T; Ishigami T; Kimura K; Tamura K
    J Cardiol; 2017 Nov; 70(5):416-419. PubMed ID: 28522137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left ventricular discoordination index measured by speckle tracking strain rate imaging predicts reverse remodelling and survival after cardiac resynchronization therapy.
    Wang CL; Powell BD; Redfield MM; Miyazaki C; Fine NM; Olson LJ; Cha YM; Espinosa RE; Hayes DL; Hodge DO; Lin G; Friedman PA; Oh JK
    Eur J Heart Fail; 2012 May; 14(5):517-25. PubMed ID: 22411692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of brain natriuretic peptide in the management of patients receiving cardiac resynchronization therapy.
    Pitzalis MV; Iacoviello M; Di Serio F; Romito R; Guida P; De Tommasi E; Luzzi G; Anaclerio M; Varraso L; Forleo C; Pansini N
    Eur J Heart Fail; 2006 Aug; 8(5):509-14. PubMed ID: 16503416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders.
    Vanderheyden M; Mullens W; Delrue L; Goethals M; de Bruyne B; Wijns W; Geelen P; Verstreken S; Wellens F; Bartunek J
    J Am Coll Cardiol; 2008 Jan; 51(2):129-36. PubMed ID: 18191736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of right ventriclular systolic function prior to cardiac resynchronization therapy: Does it make any difference?
    Abdelhamid MA; Ghanem MT; Abdelmotaleb AM
    Indian Heart J; 2017; 69(6):731-735. PubMed ID: 29174250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement of serum NT-ProBNP predicts improvement in cardiac function and favorable prognosis after cardiac resynchronization therapy for heart failure.
    Yu CM; Fung JW; Zhang Q; Chan CK; Chan I; Chan YS; Kong SL; Sanderson JE; Lam CW
    J Card Fail; 2005 Jun; 11(5 Suppl):S42-6. PubMed ID: 15948100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reverse electrical remodeling by cardiac resynchronization therapy: prevalence and clinical impact.
    Sebag FA; Martins RP; Defaye P; Hidden-Lucet F; Mabo P; Daubert JC; Leclercq C
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1219-27. PubMed ID: 22697464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term Echocardiographic Outcome in Super-Responders to Cardiac Resynchronization Therapy and the Association With Mortality and Defibrillator Therapy.
    van der Heijden AC; Höke U; Thijssen J; Willem Borleffs CJ; Wolterbeek R; Schalij MJ; van Erven L
    Am J Cardiol; 2016 Oct; 118(8):1217-1224. PubMed ID: 27586169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between frequency of atrial and ventricular ectopic beats and biventricular pacing percentage and outcomes in patients with cardiac resynchronization therapy.
    Ruwald MH; Mittal S; Ruwald AC; Aktas MK; Daubert JP; McNitt S; Al-Ahmad A; Jons C; Kutyifa V; Steinberg JS; Wang P; Moss AJ; Zareba W
    J Am Coll Cardiol; 2014 Sep; 64(10):971-81. PubMed ID: 25190230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy.
    Yu CM; Bleeker GB; Fung JW; Schalij MJ; Zhang Q; van der Wall EE; Chan YS; Kong SL; Bax JJ
    Circulation; 2005 Sep; 112(11):1580-6. PubMed ID: 16144994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Echocardiographic markers of dyssynchrony as predictors of super-response to cardiac resynchronisation therapy - a pilot study.
    Kuznetsov VA; Soldatova AM; Kasprzak JD; Krinochkin DV; Melnikov NN
    Cardiovasc Ultrasound; 2018 Oct; 16(1):24. PubMed ID: 30285762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.
    Kosztin A; Kutyifa V; Nagy VK; Geller L; Zima E; Molnar L; Szilagyi S; Ozcan EE; Szeplaki G; Merkely B
    Europace; 2016 Apr; 18(4):550-9. PubMed ID: 26116830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A metric for evaluating the cardiac response to resynchronization therapy.
    Ge Y; Ruwald AC; Kutyifa V; McNitt S; Polonsky S; Klein H; Goldenberg I; Solomon SD; Foster E; Zareba W; Moss AJ
    Am J Cardiol; 2014 Apr; 113(8):1371-7. PubMed ID: 24607029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary sinus biomarker sampling compared to peripheral venous blood for predicting outcomes in patients with severe heart failure undergoing cardiac resynchronization therapy: the BIOCRT study.
    Truong QA; Januzzi JL; Szymonifka J; Thai WE; Wai B; Lavender Z; Sharma U; Sandoval RM; Grunau ZS; Basnet S; Babatunde A; Ajijola OA; Min JK; Singh JP
    Heart Rhythm; 2014 Dec; 11(12):2167-75. PubMed ID: 25014756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT).
    Goldenberg I; Moss AJ; Hall WJ; Foster E; Goldberger JJ; Santucci P; Shinn T; Solomon S; Steinberg JS; Wilber D; Barsheshet A; McNitt S; Zareba W; Klein H;
    Circulation; 2011 Oct; 124(14):1527-36. PubMed ID: 21900084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Cardiac Resynchronization Therapy on Cardiac Remodeling and Contractile Function: Results From Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE).
    St John Sutton M; Cerkvenik J; Borlaug BA; Daubert C; Gold MR; Ghio S; Chirinos JA; Linde C; Ky B
    J Am Heart Assoc; 2015 Sep; 4(9):e002054. PubMed ID: 26363005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation of QRS duration to response to cardiac resynchronization therapy.
    Sassone B; Gambetti S; Bertini M; Beltrami M; Mascioli G; Bressan S; Fucà G; Pacchioni F; Pedaci M; Michelotti F; Bacchi Reggiani ML; Padeletti L
    Am J Cardiol; 2015 Jan; 115(2):214-9. PubMed ID: 25465934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.